
National Association of Testing Authorities, Australia
Scope of Accreditation
Pathology Queensland
Site
Gold Coast Uni Laboratory
Accreditation No.
2639
Site No.
5277
Date of Accreditation
30 May 1995
Address
Level 2, Block E, Gold Coast Uni Hospital, 1 Hospital Boulevard
Southport, QLD 4215
Australia
Contact
Availability
Services available to external clients
Supervision
GY (General)
Scope of Accreditation
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
30 Jun 2028
Last Activity Date
14 Mar 2024
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
Anatomical pathology - Tissue pathology - Coronial autopsy services | Body; Body parts | Autopsy service and reporting |
Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Detection of antigenic targets - Various | ||
Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 2 mortuary |
Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body; Body parts | Autopsy service and reporting |
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Ethanol; Paracetamol (acetaminophen); Salicylate |
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Digoxin |
Carbamazepine; Gentamicin (cidomycin, septopal, genticyn, garamycin); Phenytoin (dilantin); Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | ||
Serum | Lithium | |
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Parathyroid hormone (PTH) |
Chemical pathology - Further investigation of cardiac function | Ascitic fluid; Pleural fluid | B-type natriuretic peptide (BNP) |
Blood; Plasma | Troponin I | |
Plasma | B-type natriuretic peptide (BNP) | |
Plasma; Serum | Troponin I | |
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Haptoglobins |
Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Bilirubin; Oxyhaemoglobin |
Plasma | Haemoglobin (Hb) | |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid; Pleural fluid | Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - Total; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Potassium; Protein - Total; Sodium; Triglycerides; γ-Glutamyltransferase |
Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total | |
Lactate dehydrogenase (LDH) | ||
Other body fluids; Plasma; Serum; Urine | Osmolality | |
Other body fluids; Urine | pH | |
Peritoneal dialysis fluid | Calcium - Total; Chloride; Cholesterol - Total; Creatinine; Glucose; Lipase; Magnesium; Potassium; Sodium; Triglycerides; Urea | |
Plasma | Ammonia; Lactate | |
Plasma; Serum | Chloride; Potassium; Sodium | |
Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Protein - Total; Triglycerides; Urate; Urea; γ-Glutamyltransferase | ||
Pleural fluid | pH | |
Urine | Albumin; Amylase; Calcium - Total; Creatinine; Glucose; Magnesium; Phosphate; Protein - Total; Urate; Urea | |
Chloride; Potassium; Sodium | ||
Ammonia; Bicarbonate | ||
Chemical pathology - Investigation of porphyria | Urine | Porphobilinogen (PBG) screen |
Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free |
Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
Haematology - Examination of blood films by special staining | Blood | Malaria |
Cerebrospinal fluid (CSF) | Morphology | |
Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices |
Differential number; Morphology | ||
Reticulocytes | ||
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Echis test |
Clauss fibrinogen; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT) | ||
Heparin induced thrombotic thrombocytopenia (HITT) | ||
Anti-Xa - Apixaban; Anti-Xa - Rivaroxaban; Anti-Xa activity; Anti-thrombin III; D-dimer; Factor VIII; Heparin assay | ||
APTT heparin neutralisation; Activated partial thromboplastin time (APTT); Mixing studies - APTT; Thrombin time (TT) | ||
Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
Immunohaematology - Blood grouping | Blood; Cord blood | ABO; RhD |
Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test) |
Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies | ||
Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Red blood cell phenotyping |
Other blood group antibodies; Rh | ||
Antibody elution | ||
Cord blood | Direct antiglobulin test (DAT, direct Coombs test) | |
Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen; Fluids; Lavage | Assessment of lymphoid cell populations; Assessment of myeloid cell populations; CD10; CD103; CD117; CD11b; CD11c; CD13; CD138; CD14; CD15; CD16; CD19; CD1a; CD2; CD20; CD200; CD22; CD23; CD235a; CD25; CD3; CD30; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD64; CD7; CD79a; CD8; FMC7; HLA-DR antigen; Kappa light chains; Lambda light chains; Myeloperoxidase; T-cell receptor aβ (TCRab); T-cell receptor γδ (TCRgd); Terminal deoxynucleotidyl transferase (TdT) |
Blood | Assessment of lymphoid cell populations; Assessment of myeloid cell populations | |
Blood; Haemopoietic progenitor cells | CD34 | |
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Serum; Urine | Human chorionic gonadotropin (hCG) |
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Fluids; Stem cells | Bacteria; Pathogenic microorganisms |
Bacterial isolates | Pathogenic identification | |
Carbapenem resistant Enterobacteriaceae (CRE); Carbapenem resistant Pseudomonas aeruginosa (CRP) | ||
Pathogenic identification and antibiotic susceptibility | ||
Blood | Bacteria; Pathogenic microorganisms | |
Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Operative specimens; Respiratory specimens; Tissues | Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Operative specimens; Respiratory specimens; Tissues; Urine | Bacteria; Pathogenic microorganisms | |
Cerebrospinal fluid (CSF); Urine | Streptococcus pneumoniae antigen | |
Faeces | Clostridioides difficile toxin | |
Urine | Legionella antigen | |
Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Red blood cell morphology | ||
Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Faeces | Extended spectrum beta-lactamases (ESBL); Vancomycin resistant Enterococci (VRE) |
Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags | Bacterial growth - Sterility |
Blood transfusion bags; Bronchoscopes; Environmental swabs; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial organism identification - Acinetobacter; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
Blood transfusion bags; Bronchoscopes; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility | |
Environmental swabs; Spore strips | Bacterial growth - Sterility | |
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Vancomycin resistant Enterococci (VRE) vanA/vanB genes |
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium spp. |
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Bronchial washings; Lavage; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Oropharyngeal swabs; Washings | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Faeces | Norovirus | |
Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Operative specimens; Respiratory specimens; Tissues; Urine | Fungi detection; Yeast detection |
Fungi isolation; Yeast isolation | ||
Isolates | Yeast susceptibility | |
Fungi identification; Yeasts identification | ||
Fungi identification; Yeasts identification | ||
Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Urine | Trichomonad | |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma | Infectious mononucleosis |
Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes | Blood | Quantitative calculation of p210 positive BCR::ABL1 transcripts |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
30 Jun 2028
Last Activity Date
14 Mar 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
30 Jun 2028
Last Activity Date
14 Mar 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
30 Jun 2028
Last Activity Date
14 Mar 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
30 Jun 2028
Last Activity Date
14 Mar 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
30 Jun 2028
Last Activity Date
14 Mar 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
30 Jun 2028
Last Activity Date
14 Mar 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Anion gap; Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; p50; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2639
Site No.
5277
Print date
15 Feb 2025